Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration - An Eye Toward the Future: What Is on the Horizon in nAMD?

Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration - An Eye Toward the Future: What Is on the Horizon in nAMD? is organized by Paradigm Medical Communications, LLC.

Release Date: August 30, 2019
Expiration Date: August 30, 2020

Accreditation:
Physician Credit Designation Statement:
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education:
PAs may claim a maximum of 0.5 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Course Description:
Learning Objectives:
Upon proper completion of this activity, participants should be better able to:
• Explain the mechanisms of action (MOAs) and current clinical data on emerging pharmacotherapies and delivery systems for treatment of nAMD

Additional details will be posted as soon as information is available.